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Abstract
The association of ECG abnormalities with cardiovascular disease and risk factors has been
extensively studied in Whites and African Americans. Comparable data have not been reported in
Hispanics/Latinos. The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is a
multicenter community based prospective cohort study of men and women of diverse backgrounds
ages 18 to 74 years who self-identified as Hispanic/Latinos. Participants (N=16,415), enrolled
between March 2008 and June 2011. We describe the prevalence of minor and major ECG
abnormalities and examine their cross-sectional associations with cardiovascular disease and risk
factors. The Minnesota code criteria were used to define minor and major abnormalities of the
ECG. Prior cardiovascular disease and risk factors were based on data obtained at baseline
examination. Significant differences in prevalent ECG findings were found between men and
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women. Major ECG abnormalities were present in 9.2 %( 95% confidence interval [CI], 8.3–10.1)
of men and 6.6% (95% CI, 5.8–7.3) of women (P<.0001). The odds of having major ECG
abnormalities significantly increased with age, presence of 3 or more cardiovascular risk factors
and prevalent cardiovascular disease, in both men and women. Significant differences in major
ECG abnormalities were found among the varying groups; Puerto Ricans and Dominicans had
more major abnormalities compared to Mexican men and women. In conclusion, a large cohort of
Hispanic/Latino men and women, prevalence of major abnormalities were low yet strong
associations of major ECG abnormalities with cardiovascular disease and risk factors were
observed in both men and women.
Keywords
Electrocardiogram; Hispanic Community Health Study/Study of Latinos (SOL); cardiovascular
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Introduction
The electrocardiogram (ECG) has been used as an inexpensive and widely available
screening tool for the detection of the presence of cardiovascular disease (1, 2). The
association of ECG abnormalities and underlying cardiovascular disease and the prognostic
significance of the ECG have been extensively studied in Whites, and African Americans,
and also reported in American Indians and Americans of Japanese descent but not in
Hispanics (1–18). There is only limited information on ECG findings in the Hispanic
population (19–23). Most studies compared specific ECG findings such as QRS voltage, ST
height, and QT prolongation in racially diverse populations including Hispanics (20–23).
The HCHS/SOL includes both men and women with a wide range of age, multiple countries
of origin, and individuals with and without a history of heart disease and cardiovascular risk
factors (24). The present study compares prevalent ECG findings between Hispanic/Latino
men and women and evaluates the association of ECG findings with age and gender in the
presence or absence of underlying heart disease and cardiovascular risk factors. Specifically,
it examines the prevalence of minor and major baseline ECG abnormalities and their
association with underlying cardiovascular disease and risk factors in a diverse group of
Hispanic/Latino men and women.
Methods
The HCHS/SOL is a population-based cohort study designed to examine risk and protective
factors for chronic diseases and to quantify morbidity and mortality prospectively. Details of
the sampling methods and design have been published. (24,25,26). Briefly, between March
2008 and June 2011, 16 415 self-identified Hispanic/Latino persons of diverse background
(Cubans, Dominicans, Mexicans, Puerto Ricans, Central Americans, and South Americans)
aged 18 to 74 years were examined. Participants were recruited from randomly selected
households in 4 US communities (Bronx, New York; Chicago, Illinois; Miami, Florida; San
Diego, California). Households were selected using a stratified 2-stage area probability
sample design. (25,26). Census block groups were randomly selected in the defined
community areas of each field center, and households were randomly selected in each
sampled block group. Households were screened for eligibility, and Hispanic/Latino persons
aged 18 to 74 years were selected in each household agreeing to participate. Oversampling
occurred at each stage, with block groups in areas of Hispanic/ Latino concentration,
households associated with a Hispanic/Latino surname, and persons aged 45 to 74 years
selected at higher rates than their counterparts. Sampling weights were generated to reflect
the probabilities of selection at each stage. The study was approved by the institutional
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review board at each participating institution; written informed consent was obtained from
all participants (24,25,26).
The study design and study protocol and implementation have been previously published in
detail (24,25,26). The baseline examination included medical history, medication use, family
history, tobacco use, anthropometry, blood pressure, phlebotomy for laboratory studies and
an ECG. Major CVD risk factors were defined based on current national guidelines.
Hypercholesterolemia and dyslipidemia were defined as total cholesterol 240 mg/dL or
greater, LDL cholesterol 160 mg/dL or greater, or HDL cholesterol less than 40 mg/dL (for
persons with and without diabetes) or receiving cholesterol-lowering medication (24).
Hypertension was a systolic blood pressure 140 mm Hg or greater, diastolic blood pressure
90 mm Hg or greater or receiving antihypertensive medication (24). Diabetes mellitus was a
fasting plasma glucose 126 mg/dL or greater, 2-hour post-load plasma glucose 200 mg/dL or
greater, an HbA1c 6.5% or greater, or use of antihyperglycemic medications (24). Blood
pressure and heart rate were measured by standard epidemiology procedures (5 minutes rest,
3 measures), using an automated blood pressure device [Omron model HEM-907
XL(Omron Healthcare Inc, Bannockburn, IL)] in a seated position. Smoking status was
categorized as current smoker, past smoker, and never smoked. A positive family history of
CVD was defined as answering yes to the question of having a first degree relative who had
a heart attack at age < 55 years old. The presence of prior CVD was ascertained by
answering yes to the questions of having had prior heart attack, coronary revascularization
(CABG or PTCA/stent), rheumatic heart disease, heart failure or stroke/TIA. ECGs were
obtained after an overnight fast and at least 2 hours after glucose load administration.
Resting standard, 10 second, simultaneous 12-lead ECG was digitally acquired using a GE
MAC 1200 electrocardiograph (GE, Milwaukee, WI) at 10 mm/mV calibration and speed of
25 mm/s. ECG reading was performed centrally at the Epidemiological Cardiology Research
Center (EPICARE), Wake Forest School of Medicine, Winston Salem, NC. All ECGs were
initially inspected visually for technical errors and inadequate quality before being
automatically processed using GE 12-SL Marquette Version 2001(GE, Milwaukee, WI).
ECG abnormalities were classified and coded using the Minnesota ECG Classification (27).
In addition to the individual ECG abnormalities, ECG tracings were classified as having a
major or minor abnormality. Participants with only minor ECG abnormalities were
classified as having “any minor abnormalities,” and participants with major ECG
abnormalities with or without coexisting minor ECG abnormalities were classified as having
“any major ECG abnormalities.” Major ECG abnormalities included: Major ventricular
conduction defect; definite myocardial infarction (defined as the presence of major Q wave
abnormalities); possible myocardial infarction (defined as the presence of minor Q-QS wave
plus major ST-T abnormalities); major isolated ST-T abnormalities; left ventricular
hypertrophy plus major ST-T abnormalities; major atrio-ventricular conduction
abnormalities; major QT prolongation (QTI≥116% or JTI if QRS ≥120ms), pacemaker, and
other major arrhythmias. Minor ECG abnormalities included: Minor isolated Q-QS waves;
minor isolated ST-T abnormalities; high R waves; ST segment elevation; incomplete right
bundle branch block; minor QT prolongation (QTI≥112% or JTI if QRS≥120 ms); short PR
interval; left axis deviation; right axis deviation; frequent ventricular premature beats; and
other minor abnormalities.
In addition to the Minnesota code defined ECG abnormalities, the automatically calculated
global measurements of QT, PR, and QRS were also obtained. To calculate QTc interval
from the raw QT and heart rate, recommendation of using linear models for adjustment for
QTc from the American Heart Association (AHA), American College of Cardiology (ACC)
and Heart Rhythm Society (HRS) for the Standardization and Interpretation of the
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Electrocardiogram were followed(28). Therefore, the Framingham linear regression formula
[QTc = QT +0.154 (1−{60/heart rate})] was used (29). QTc values of 460 ms or longer in
women and 450 ms or longer in men were considered abnormal (i.e. prolonged QTc) (27).
The HCHS/SOL cohort was recruited with use of a stratified two-stage area probability
sampling design in which participant’s households were sampled from augmented
residential mailing lists from pre-selected census block groups within each of the four
regional field centers. The target population was the non-institutionalized Hispanic/Latino
population ages 18–74 residing in the defined community areas. Trimmed, normalized
sampling weights adjusted for non-response for enumerated but non-enrolled household
members were derived and later calibrated to the 2010 US Census. Complete details of the
sampling design have been reported in a technical report prepared by the study coordinating
center. To account for the complex sampling design, all reported means and proportions are
weighted. Model based means, proportions, odds ratios and p-values were obtained by
fitting linear and logistic regression models for complex survey data. Standard errors were
computed by using Taylor linearization method. All analysis were performed using SAS 9.3
survey specific procedures (SAS Institute, Cary, NC). Participants with missing ECG
readings (N=203) and missing data on CVD risk factors (N=284); includes (9 participants >
74 years old, and 152, 49, 18, 71, 144 and 13 missing one or more of serum cholesterol,
BMI, blood pressure, smoking, family history of CVD or diabetes status, respectively) and
CVD status variables (N=116) were excluded from all analyses, leaving 15,812 participants
in the analysis sample. To preserve the study design and ensure that the standard errors are
computed correctly, the exclusions were made by using the DOMAIN statement in SAS
survey procedures. Weighted prevalence percents have been age standardized to the year
2000 Census to make them more comparable to NHANES data (30).
Results
Baseline characteristics of the study group are shown in Table 1. At baseline examination,
men had higher prevalence of history of hypercholesterolemia, being current smokers,
having history of heart attack and coronary revascularization; they had higher systolic and
diastolic blood pressure. Women were older, more obese, and had faster heart rates.
The prevalent age adjusted major and minor ECG abnormalities comparing men and women
are shown in Table 2. Major ECG abnormalities were more frequent in men. The three more
common major ECG abnormalities in men were major Q waves (MC 1.1, 1.2), ventricular
conduction defects (MC 7.1, 7.2, 7.4, 7.8) and major isolated ST-T abnormalities (MC 4.1 o
4.2 or 5.1 or 5.2). In women these ECG abnormalities had also the highest prevalence but
compared to men the prevalence of major Q waves (MC 1.1, 1.2), and ventricular
conduction defects (MC 7.1, 7.2, 7.4, 7.8) were significantly lower and major isolated ST-T
abnormalities (MC 4.1 o 4.2 or 5.1 or 5.2) were higher. There were significant differences in
the prevalence of certain minor ECG abnormalities. Men had a higher prevalence of minor
isolated Q waves (MC 1.3), tall R waves (MC 3.1, 3.3, 3.4), ST elevation (MC 9.2),
incomplete right bundle branch block (MC 7.3), left axis deviation (MC 2.1), frequent VPB
(8.1.2, 8.1.3) and sinus bradycardia (MC 8.8). Women had a higher prevalence of minor
isolated ST-T abnormalities (MC 4.3, 4.4, 5.3, 5.4), low QRS voltage (MC 9.1) and minor
QT prolongation index.
The comparison of the prevalent ECG findings and major and minor ECG abnormalities by
CVD risk status or disease in men and women is shown in Tables 3 and 4. There was a
significant trend, in both men and women, for increasing heart rate, QRS and QTc duration
and QT prolongation index as the number of CVD risk factors increased or in the presence
of prevalent CVD, compared to those with no CVD risk factors. Examining major ECG
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abnormalities in men there was a significant trend for increasing prevalence of major Q
waves (MC 1.1, 1.2), major isolated ST-T abnormalities (MC 4.1 o 4.2 or 5.1 or 5.2), left
ventricular hypertrophy plus major ST-T abnormality {MC 3.1+ (4.1 or 4.2 or 5.1 or 5.2)}
and ventricular conduction defects (MC 7.1, 7.2, 7.4, 7.8) with the number of CVD risk
factors and prevalent CVD. The prevalence of any major ECG abnormality was 6.22% in
men without CVD risk factors or disease and 28.44% in those with prevalent CVD. In
women the prevalence of any major ECG abnormality was 5.40% in those without CVD risk
factors or disease and 16.71% in those with prevalent CVD. In women, significant trends
were observed for the presence of major Q waves (MC 1.1, 1.2), major isolated ST-T
abnormalities (MC 4.1 o 4.2 or 5.1 or 5.2), left ventricular hypertrophy plus major ST-T
abnormality {MC 3.1+ (4.1 or 4.2 or 5.1 or 5.2)} and major QT prolongation index (QTI ≥
116) with the number of CVD risk factors and prevalent CVD. Examining minor ECG
abnormalities in men there was a significant trend for higher prevalence of minor isolated
ST-T abnormalities (MC 4.3, 4.4, 5.3, 5.4) with higher risk factor burden. An inverse trend
for ST elevation (MC 9.2) and sinus bradycardia was present with greater risk factor burden.
ST elevation (MC 9.2) was observed in 15.24% of men without CVD risk factors or disease;
these were most commonly seen in the inferior leads. In women significant trends were
observed for the presence of minor isolated Q waves (MC 1.3), minor isolated ST-T
abnormalities (MC 4.3, 4.4, 5.3, 5.4), and tall R waves (MC 3.1, 3.3, 3.4)across the risk
factor burden groups. ST elevation in women showed no reverse trend and the prevalence
was low (0.78%) in those without CVD risk factors or disease.
Cross-sectional associations of major ECG abnormalities with CVD risk factors, prevalent
CVD, and ethnic background are shown in figure 1. The odds of having major ECG
abnormalities was significantly increased in men with age (1 SD delta), history of
hypertension, diabetes, current smoker status, heart rate(1 SD delta), systolic and diastolic
blood pressure(1 SD delta), 3 or three or more risk factors or prevalent cardiovascular
disease. Similar significant associations were found in women except for current smoking
status, diastolic blood pressure and three or more CVD risk factors. The odds ratios of
having major ECG abnormalities increased in all age groups (years, 35–54, 55–64 and 65 or
greater) of both men and women compared to the reference group (years 18–34), even when
adjusted for CAD risk factors. The adjusted odds ratio for men age 65 or more for having
major ECG abnormalities was 5.6 compared to the reference group and it was 3.5 for
women.
The analysis of the effect of age on major ECG abnormalities is shown in figure 2. The
population weighted prevalence (%) of major ECG abnormalities was higher at older ages in
both men and women. The prevalence of major ECG abnormalities increased from 5.7% in
the second decade (18–29 years) to 32.4% in the seventh decade (70–74 years) in men and
4.7% to 14.9% for the corresponding age groups for women. Interestingly, the first
significant increase occurred in the fifth decade when the prevalence of major ECG
abnormalities doubled.
The HCHS/SOL included participants from Mexican, Cuban, Puerto Rican, Dominican,
Central American and South American background. In order to examine if significant
differences existed in the odds of having major ECG abnormalities among these groups we
designated the Mexican group as reference because they had the largest number of
participant in the study. Significant differences in the odds of having major ECG
abnormalities were found by ethnic background. The odds of having major ECG
abnormalities were significantly higher in Dominicans and Puerto Ricans men and women
compared to Mexicans (Figure 1).
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The existing data on ECG findings are derived from largely white population (1, 3–5, 7,8,
10, 11, 14). However, a number of studies have focused on groups with different racial
backgrounds. The Strong Heart study examined ECG abnormalities among American
Indians (17). The Honolulu Heart Program examined the predictive value of ECG in men of
Japanese descent (18). The Evans County and Charleston Heart studies showed that African-
Americans have a higher prevalence of ECG abnormalities and less coronary heart disease
than White men (6,9). Differences in ECG abnormalities were found in the biracial
population of the ARIC, CARDIA and REGARDS studies (12,13,15,16). African American
men and women have higher prevalence of ECG abnormalities than Whites (6,9,12,15,16).
Other studies reported differences in specific ECG measures such as, QT and QT
subintervals, QRS amplitudes, left ventricular hypertrophy and in ST heights in ethnically
diverse population (20–23). The largest and most comprehensive study on the value of the
ECG in Hispanics was reported from the Palo Alto Veterans Affair (PAVAS) Health Care
System (19). The study included 2,625 Hispanic and 41,546 non-Hispanic patients, with
>90% of them being men. There were fewer CVD deaths in the Hispanic group compared to
the non-Hispanics. There were also significant differences in ECG abnormalities between
the two groups with the Hispanic showing fewer ECG abnormalities. The study did not
report on the major and minor ECG abnormalities but the more frequent abnormalities
included pathologic Q waves (10.6%) and left axis deviation (9.3%). The analysis was not
adjusted for age, or the presence of underlying heart disease and risk factors.
There has been no large community based prospective cohort study examining the
prevalence of ECG abnormalities in Hispanic/Latinos. This report on a community based
prospective cohort study of large number of Hispanic/Latino men and women provides
prevalence estimates of minor and major baseline ECG abnormalities and their associations
with underlying cardiovascular disease and risk factors. It also evaluates the effect of age
and gender on ECG characteristics. Findings are presented separately for men and women.
Data are also weighted to reflect the non-institutional Hispanic/Latino adults residing in the
defined community areas of recruitment in each of the four field centers as well as to
facilitate subsequent comparison between ethnic groups.
Significant differences in ECG findings between Hispanic/Latino men and women were
found. The prevalence of any major ECG abnormality was 6.22% in men without CVD risk
factors or disease and 28.44% in those with prevalent CVD. In women the prevalence of any
major ECG abnormality was 5.40% in those without CVD risk factors or disease and
16.71% in those with prevalent CVD. Our results confirm the findings of previous studies
not including Hispanic/Latino participants showing a higher prevalence of major ECG
abnormalities in men compared to women (1). The more common major abnormalities in
men were major Q waves in 2.76 %, and major isolated ST-T abnormalities in 3.04%, while
in women these were 1.36% and 3.62%, respectively. The more common minor
abnormalities in men were ST segment elevation in 10.18% and, minor isolated Q/QS waves
in 7.71%, while in women these were 1.41% and 5.75%, respectively. We confirmed
previous observations on the association of ST segment elevation with male gender and
younger age (1).
The direct association between age and prevalence of major ECG abnormalities was also
confirmed by our study (1). The odds ratio of having major ECG abnormalities significantly
increased with age, presence of 3 or more cardiovascular risk factors and prevalent
cardiovascular disease, in both men and women. The population weighted prevalence of
major ECG abnormalities increased from 5.7% in the second decade (18–29 years) to 32.4%
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in the seventh decade (70–74 years) in men and 4.7% to 14.9% for the corresponding age
groups for women.
An interesting finding of our study is the observation that major ECG abnormalities are
significantly more likely to be found in both men and women of Puerto Rican and
Dominican background compared to Mexicans. This is consistent with the findings of the
previous publication on CVD risk factors in Hispanic/Latino individuals, showing that
participants with Puerto Rican background have higher prevalence of adverse CVD risk
profiles (24). We hypothesize that the higher prevalence of major ECG abnormalities in
Dominicans is related to a higher prevalence of participants of African descent. It has been
shown that African -Americans have a higher prevalence of ECG abnormalities than non-
Hispanic Whites (6,9,12,15,16). Further studies are needed to confirm these findings and
understand the etiology and mechanism underlying them.
A methodological limitation of the study is that the presence of underlying CVD and some
of the risk factors are self-reported and not based on review of medical records. A
significant shortcoming of the present report is the absence of follow-up data at the present
time to evaluate the prognostic significance of the ECG findings. The major strength
includes large cohort study, diverse population of Hispanic/Latinos, uniform measurements,
interpretation and reporting of the ECG data by using the Minnesota code classification and
computerized ECG from a central reading center (EPICARE).
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Baseline characteristic by normal or minor vs. major ECG abnormalities.
Figure 1a. 6,333 HCHS/SOL male participants. Figure 1b. 9,479 HCHS/SOL female
participants. Age-adjusted odds ratios and 95 % confidence intervals. Ethnic background
odd ratios are further adjusted for hypertension (or medication), hyperlipidemia (or
medication), obesity, diabetes (or medication) & current smoking. CVD = Cardiovascular
Disease; Diab= Diabetes; Htn = hypertension; Rx = medication.
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Population weighted prevalence (%) of major ECG abnormalities by age group and gender.
Data are presented in percentages for six decades of age for both men and women.
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Table 1
Baseline Characteristics of 15,812 HCHS/SOL Participantsa
Characteristic Men (N=6,333) Women (N=9,479) p-valueb
Age (years)
 18–34 40.4% 36.7% 0.0006
 35–54 40.3% 40.5% 0.8471
 55–64 11.8% 13.4% 0.0023
 65+ 7.5% 9.3% 0.0036
Age (years), mean (SD) 40.23 (0.31) 41.80 (0.28) <.0001
Hypertension or antihypertensive medication, 21.9% 21.5% 0.6698
Hypercholesterolemia or lipid lowering medications, 50.1% 35.0% <.0001
Diabetes mellitus or diabetes medication, 13.7% 15.5% 0.0196
Smoking status
 Current 26.8% 16.4% <.0001
 Former 21.8% 12.8% <.0001
 Never 51.4% 70.8% <.0001
Family history heart attack < Age 55 6.8% 8.3% 0.0109
Body mass index (kg/m2)
 < 25 22.7% 23.6% 0.4271
 25–< 30 40.8% 33.9% <.0001
 ≥ 30 36.5% 42.5% <.0001
Systolic blood pressure (mmHg), mean (SD) 123.40 (0.28) 116.70 (0.32) <.0001
Diastolic blood pressure (mmHg), mean (SD) 73.53 (0.23) 70.96 (0.21) <.0001
Heart rate (bpm), mean (SD) 61.85 (0.26) 63.77 (0.17) <.0001
Total cholesterol (mg/dl), mean (SD) 194.48 (0.81) 194.27 (0.68) 0.8339
Prior cardiovascular disease
 Prior myocardial infarction 2.6% 1.4% 0.0001
 Revascularization, (CABG, PCI, Stent) 1.7% 1.0% 0.0003
 Prior Stroke / TIA 2.3% 2.2% 0.7178
 Rheumatic heart disease 0.3% 0.7% 0.0323
 Heart failure 1.6% 2.0% 0.1607
 Mexican 36.9% 38.5% 0.1318
 Cuban 22.1% 18.5% <.0001
 Puerto Rican 16.5% 14.7% 0.0249
 Dominican 8.2% 11.7% <.0001
 Central American 7.4% 7.5% 0.8061
 South American 4.7% 5.1% 0.2487
 Other / Mixed / Unknown 4.3% 4.1% 0.6378
Abbreviations: BMI, body mass index; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; TIA, transient ischemic
attack.
a
All values (except number of persons in headings) weighted for study design and non-response with use of SURVEY versions of SAS procedures.
Percents represent column percents from the corresponding 2x2 table with only participants with the indicated condition or trait displayed.
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b
P-values from chi-square for 2x2 cross tabulation for discrete variables or t-test for continuous variables.
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Table 2
Prevalent Electrocardiographic Abnormalities in 15,812 HCHS/SOL Participants (Age Standardized)a
Abnormality Men (n=6,333) Women (n=9,479) p-valueb
Major Minnesota Code Abnormalities Percent (95% CI)
Major Q wave abnormalities (MC 1.1, 1.2) 2.76 (2.21–3.31) 1.36 (0.94–1.78) <.0001
Minor Q wave plus major ST-T abnormalities (MC 1.3 + (4.1 or 4.2 or 5.1 or 5.2)) 0.29 (0.17–0.42) 0.37 (0.19–0.55) 0.4862
Major isolated ST-T abnormalities (MC 4.1 or 4.2 or 5.1 or 5.2) 3.04 (2.53–3.56) 3.62 (3.10–4.14) 0.1171
Left ventricular hypertrophy w/ major ST-T abn (MC 3.1 or 3.4) + (4.1 or 4.2 or 5.1 or
5.2)
0.53 (0.31–0.76) 0.21 (0.12–0.31) 0.0138
Atrial fibrillation/flutter (MC 8.3) 0.30 (0.11–0.49) 0.04 (0.00–0.08c) 0.0095
Ventricular conduction defects (MC 7.1, 7.2, 7.4, 7.8) 3.39 (2.88–3.90) 1.36 (1.01–1.71) <.0001
 Complete/intermittent LBBB (MC 7.1) 0.21 (0.10–0.32) 0.26 (0.12–0.39) 0.5955
 Complete/intermittent RBBB (MC 7.2) 1.53 (1.20–1.85) 0.71 (0.45–0.97) <.0001
 Nonspecific IVCD (MC 7.4) 1.43 (1.04–1.81) 0.37 (0.16–0.57) <.0001
 Complete/intermittent RBBB with left anterior hemiblock (MC 7.8) 0.23 (0.06–0.39) 0.03 (−0.00–0.05c) 0.0214
Major AV conduction abnormalities (MC 6.1, 6.2) 0.00 (−0.00–0.01c) 0.00 (−0.00–0.01c) 0.8995
WPW (MC 6.4) 0.06 (−0.02–0.13c) 0.03 (−0.00–0.05c) 0.4198
Major QT prolongation index (QTI ≥ 116 or JTI if QRS ≥ 120) 0.58 (0.31–0.84) 0.54 (0.36–0.73) 0.8337
Other major arrhythmias (MC 8.2, 8.4.2 or 8.4.1 w/ HR ≥ 140) 0 0 --
Artificial pacemaker (MC 6.8) 0.22 (0.07–0.37) 0.02 (−0.01–0.05c) 0.0132
Any major ECG abnormality 9.20 (8.34–10.06) 6.55 (5.78–7.32) <.0001
Minor Minnesota Code abnormalities
Minor isolated Q waves (MC 1.3) 7.71 (6.85–8.57) 5.75 (4.90–6.61) 0.0009
Minor isolated ST, T abnormalities (MC 4.3, 4.4, 5.3, 5.4) 5.38 (4.66–6.11) 6.65 (5.80–7.51) 0.0253
Tall R waves left (MC 3.1, 3.3, 3.4) 7.15 (6.21–8.08) 3.02 (2.43–3.62) <.0001
Low voltage (MC 9.1) 0.82 (0.54–1.10) 2.49 (2.10–2.88) <.0001
Tall R wave right (MC 3.2) 0.46 (0.18–0.74) 0.02 (−0.01–0.04c) 0.0024
ST elevation (MC 9.2) 10.18 (9.14–11.21) 1.41 (1.05–1.78) <.0001
 ST elevation (MC 9.2): Anterior leads 3.10 (2.49–3.71) 0.72 (0.42–1.01) <.0001
 ST elevation (MC 9.2): Lateral leads 1.63 (1.19–2.07) 0.55 (0.32–0.79) <.0001
 ST elevation (MC 9.2): Inferior leads 7.85 (6.93–8.77) 0.54 (0.33–0.75) <.0001
Incomplete RBBB (MC 7.3) 2.63 (1.95–3.30) 1.82 (1.39–2.25) 0.0411
Left axis deviation (MC 2.1) 2.30 (1.82–2.78) 1.35 (0.82–1.88) 0.0109
Right axis deviation (MC 2.2) 0.08 (0.02–0.14) 0.00 (−0.00–0.01c) 0.0113
Minor QT prolongation index (QTI ≥ 112 < 116 or JTI if QRS ≥ 120) 0.66 (0.46–0.87) 2.55 (1.92–3.18) <.0001
Frequent VPB (MC 8.1.2, 8.1.3, 8.1.5) 0.98 (0.64–1.31) 0.53 (0.32–0.74) 0.0308
Sinus bradycardia (MC 8.8) 8.50 (7.47–9.53) 4.20 (3.65–4.74) <.0001
Other minor abnormalities (MC 6.3, 6.5, 8.1.1, 8.1.4, 8.4.1, 8.7, 9.3) 6.70 (5.82–7.58) 6.48 (5.76–7.21) 0.7091
Abbreviations: ECG, electrocardiogram; LBBB, left bundle branch block; RBBB, right bundle branch block; IVCD, intraventricular conduction
delay; AV, atrio-ventricular; WPW, Wolff-Parkinson-White; VPB, ventricular premature beats.
a
All values (except number of persons in headings) weighted for study design and non-response with use of SURVEY versions of SAS procedures
and Age Standardized to the 2000 US Population.
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b
Age-adjusted p-value for difference between men and women from SAS SURVEYREG procedure.
c
Cell contains fewer than five observations.
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